- Point of care infectious disease diagnostics are becoming increasingly vital in healthcare systems across both developed and developing regions, due to their ability to deliver rapid results at or near the site of patient care. These diagnostics play a crucial role in early detection, timely treatment, and effective containment of infectious diseases such as influenza, HIV, COVID-19, malaria, and tuberculosis
- The escalating demand for point of care infectious disease diagnostics is primarily fueled by the growing prevalence of infectious diseases, rising demand for decentralized testing, and increasing adoption of rapid diagnostic technologies in emergency settings, clinics, and remote locations
- North America dominated the point of care infectious disease diagnostics market with the largest revenue share of 38.6% in 2024, driven by advanced healthcare infrastructure, high awareness levels, and substantial investment in R&D. The U.S. leads the region, supported by early adoption of cutting-edge diagnostic platforms and a strong presence of key market players
- Asia-Pacific is expected to be the fastest-growing region in the point of care infectious disease diagnostics market during the forecast period, projected to expand at a CAGR of 12.4% from 2025 to 2032. Factors such as increasing urbanization, rising healthcare expenditure, and government initiatives for strengthening primary healthcare infrastructure contribute to this growth. Countries such as China, India, and Southeast Asian nations are witnessing significant demand for affordable, portable, and accurate diagnostic tools for infectious disease management
- The lateral flow assay segment dominated the point of care infectious disease diagnostics market with a market share of 43.2% in 2024, attributed to its ease of use, quick turnaround time, and widespread application in detecting infections such as COVID-19, HIV, and influenza. The segment continues to be the preferred choice in low-resource settings and during public health emergencies due to its cost-effectiveness and minimal need for complex laboratory equipmen
